Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: A randomized clinical trial

JAMA

Volumn 310, Issue 3, 2013, Pages 270-279

  Mentzelopoulos, Spyros D ^a   Malachias, Sotirios ^a   Chamos, Christos ^b   Konstantopoulos, Demetrios ^b   Ntaidou, Theodora ^b   Papastylianou, Androula ^a   Kolliantzaki, Iosifinia ^a   Theodoridi, Maria ^b   Ischaki, Helen ^a   Makris, Dimosthemis ^c   Zakynthinos, Epaminondas ^c   Zintzaras, Elias ^c,d   Sourlas, Sotirios ^e   Aloizos, Stavros ^e   Zakynthinos, Spyros G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e 401 Army Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HYDROCORTISONE; METHYLPREDNISOLONE; OXYGEN; PLACEBO; VASOPRESSIN;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CEREBRAL PERFORMANCE CATEGORY SCORE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GREECE; HEART ARREST; HEART HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; IN HOSPITAL CARDIAC ARREST; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OXYGEN SATURATION; PARALLEL DESIGN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SHOCK; SURVIVAL RATE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84880322867     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.7832     Document Type: Article

References (38)

1. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557-563. (Pubitemid 34438816)
2. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549-556.
3. Aufderheide TP, Frascone RJ, Wayne MA, et al. Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial. Lancet. 2011;377(9762):301- 311.
4. Aufderheide TP, Nichol G, Rea TD, et al Resuscitation Outcomes Consortium (ROC) Investigators. A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med. 2011;365(9):798-806.
5. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH; European Resuscitation Council Vasopressor during Cardiopulmonary Resuscitation Study Group. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350(2):105-113. (Pubitemid 38056221)
6. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs epinephrine alone in cardiopulmonary resuscitation. N Engl J Med. 2008;359(1):21-30. (Pubitemid 351931093)
7. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med. 2009;169(1):15-24.
8. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation. 2002;106(5):562-568. (Pubitemid 34827705)
9. Nolan JP, Deakin CD, Soar J, Böttiger BW, Smith G; European Resuscitation Council. European Resuscitation Council guidelines for resuscitation 2005: Section 4, Adult advanced life support. Resuscitation. 2005;67(suppl 1):S39-S86. (Pubitemid 41729023)
10. Shizukuda Y, Miura T, Ishimoto R, Itoya M, Iimura O. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. Can J Cardiol. 1991;7(10):447-454.
11. Dellinger RP, Levy MM, Carlet JM, et al International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society;World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.
12. Cummins RO, Chamberlain D, Hazinski MF, et al American Heart Association. Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital "Utstein style." Circulation. 1997;95(8):2213-2239. (Pubitemid 27184295)
13. The Brain Resuscitation Clinical Trial II Study Group. A randomized clinical trial of calcium entry blocker administration to comatose survivors of cardiac arrest: design, methods, and patient characteristics. Control Clin Trials. 1991;12(4):525-545.
14. von Lewinski D, Bruns S, Walther S, Kögler H, Pieske B. Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation. 2005;111(20):2588-2595. (Pubitemid 40740857)
15. O'Connor E, Fraser JF. The interpretation of perioperative lactate abnormalities in patients undergoing cardiac surgery. Anaesth Intensive Care. 2012;40(4):598-603.
16. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004;126(3):879-887. (Pubitemid 39258045)
17. Nilsson F, Bake B, Berglin E, et al. Glucose and insulin infusion directly after cardiac surgery: effects on systemic glucose uptake, catecholamine excretion, O2 consumption, and CO2 production. JPEN J Parenter Enteral Nutr. 1985;9(2):159-164. (Pubitemid 15100547)
18. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med. 2007;33(2):237-245. (Pubitemid 46221228)
19. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med. 2010;38(1):101-108.
20. Ong ME, Tan EH, Ng FS, et al Cardiac Arrest and Resuscitation Epidemiology Study Group. Survival outcomes with the introduction of intravenous epinephrine in the management of out-of-hospital cardiac arrest. Ann Emerg Med. 2007;50(6):635-642. (Pubitemid 350110492)
21. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA. 2009;302(20):2222-2229.
22. Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL. Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial. Resuscitation. 2011;82(9):1138-1143.
23. Hagihara A, Hasegawa M, Abe T, Nagata T, Wakata Y, Miyazaki S. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA. 2012;307(11):1161-1168.
24. Ristagno G, Tang W, Huang L, et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med. 2009;37(4):1408-1415.
25. Ristagno G, Sun S, Tang W, Castillo C, Weil MH. Effects of epinephrine and vasopressin on cerebral microcirculatory flows during and after cardiopulmonary resuscitation. Crit Care Med. 2007;35(9):2145-2149. (Pubitemid 47326452)
26. Voelckel WG, Lurie KG, McKnite S, et al. Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med. 2002;30(5):957-962. (Pubitemid 34508013)
27. Ristagno G, Tang W, Sun S, Weil MH. Cerebral cortical microvascular flow during and following cardiopulmonary resuscitation after short duration of cardiac arrest. Resuscitation. 2008;77(2):229-234.
28. Ertmer C, Bone HG, Morelli A, et al. Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock. 2007;27(3):281-288.
29. Tsuneyoshi I, Kanmura Y, Yoshimura N. Methylprednisolone inhibits endotoxin-induced depression of contractile function in human arteries in vitro. Br J Anaesth. 1996;76(2):251-257. (Pubitemid 26043457)
30. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation. 1995;92(10):3089-3093.
31. Chang WT, Ma MH, Chien KL, et al. Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med. 2007;33(1):88-95. (Pubitemid 46115474)
32. Skyschally A, Haude M, Dörge H, et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronarymicroembolization. Circulation. 2004;109(19):2337-2342. (Pubitemid 38678523)
33. Peberdy MA, Callaway CW, Neumar RW, et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18)(suppl 3):S768-S786.
34. Mentzelopoulos SD, Zakynthinos SG, Siempos I, Malachias S, Ulmer H, Wenzel V. Vasopressin for cardiac arrest:meta-analysis of randomized controlled trials. Resuscitation. 2012;83(1):32-39.
35. Tsai MS, Huang CH, Chang WT, et al. The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg Med. 2007;25(3):318-325. (Pubitemid 46357669)
36. Baumann G, Dingman JF. Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest. 1976;57(5):1109-1116.
37. Annane D, Bellissant E, Sebille V, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol. 1998;46(6):589-597.
38. Funding/Support: This work has been funded in part by the Greek Society of Intensive Care Medicine and the Project "Synergasia" (ie, Cooperation) of the Greek Ministry of Education (O9ΣYN-12-1075). All funding was used for purchasing necessary materials for the study (eg, study drugs, study drug boxes, syringes) and for partial coverage of expenses related to a scientific congress presentation.